RE: RE: RE: RE: "Gang of three" leaving - so what? Just receive the following email from Sarah Z. "Our CSC members participate on multiple advisory boards and are involved in numerous publications and trials. As a KOL, there exists a general interest in having a positive impact on the overall burden of cardiovascular disease. Therefore, multiple approaches are considered when seeking new technologies for CVD reduction. We are fortunate to have such KOL's as advisors to Resverlogix. If you need more help understanding thismI can be reached by phone today"
SF....I suggest you make the call as I'm not fluent in this space.